S.2901 - Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2019116th Congress (2019-2020)
|Sponsor:||Sen. Collins, Susan M. [R-ME] (Introduced 11/19/2019)|
|Committees:||Senate - Finance|
|Latest Action:||11/19/2019 Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S6673) (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: S.2901 — 116th Congress (2019-2020)All Information (Except Text)
Introduced in Senate (11/19/2019)
Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2019
This bill establishes the Task Force on Innovative Diabetes Technologies and Services to address the accessibility of innovative diabetes technologies and services to Medicare beneficiaries. The bill defines innovative diabetes technologies and services as medical technologies and services for diabetes treatment that are not covered under Medicare.
Among other activities, the task force must (1) recommend ways to improve access to innovative diabetes technologies and services through new or alternative payment models and existing policies, and (2) propose changes to foster collaboration between the Food and Drug Administration and the Centers for Medicare & Medicaid Services to streamline approval and coverage.